Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZN) EBIT (2021 - 2025)

Surrozen (SRZN) has 5 years of EBIT data on record, last reported at -$10.9 million in Q3 2025.

  • For Q3 2025, EBIT fell 983.52% year-over-year to -$10.9 million; the TTM value through Sep 2025 reached -$38.0 million, down 42.65%, while the annual FY2024 figure was -$25.5 million, 44.21% up from the prior year.
  • EBIT reached -$10.9 million in Q3 2025 per SRZN's latest filing, down from -$9.0 million in the prior quarter.
  • Across five years, EBIT topped out at $1.2 million in Q3 2024 and bottomed at -$37.3 million in Q3 2021.
  • Average EBIT over 5 years is -$11.7 million, with a median of -$10.9 million recorded in 2025.
  • Peak YoY movement for EBIT: skyrocketed 111.01% in 2024, then tumbled 983.52% in 2025.
  • A 5-year view of EBIT shows it stood at -$15.0 million in 2021, then skyrocketed by 85.54% to -$2.2 million in 2022, then plummeted by 348.32% to -$9.7 million in 2023, then grew by 11.64% to -$8.6 million in 2024, then dropped by 26.69% to -$10.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$10.9 million in Q3 2025, -$9.0 million in Q2 2025, and -$9.6 million in Q1 2025.